South Korea
· Delayed Price · Currency is KRW Englewood Lab Statistics
Total Valuation
Englewood Lab has a market cap or net worth of KRW 261.28 billion. The enterprise value is 252.54 billion.
| Market Cap | 261.28B |
| Enterprise Value | 252.54B |
Important Dates
The last earnings date was Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Englewood Lab has 20.14 million shares outstanding. The number of shares has decreased by -0.91% in one year.
| Current Share Class | 20.14M |
| Shares Outstanding | 20.14M |
| Shares Change (YoY) | -0.91% |
| Shares Change (QoQ) | +12.41% |
| Owned by Insiders (%) | 5.01% |
| Owned by Institutions (%) | 1.83% |
| Float | 7.20M |
Valuation Ratios
The trailing PE ratio is 15.85 and the forward PE ratio is 13.92.
| PE Ratio | 15.85 |
| Forward PE | 13.92 |
| PS Ratio | 1.42 |
| PB Ratio | 1.86 |
| P/TBV Ratio | 1.88 |
| P/FCF Ratio | 20.61 |
| P/OCF Ratio | 15.78 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.46, with an EV/FCF ratio of 19.92.
| EV / Earnings | 17.43 |
| EV / Sales | 1.47 |
| EV / EBITDA | 11.46 |
| EV / EBIT | 15.08 |
| EV / FCF | 19.92 |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.70 |
| Quick Ratio | 1.90 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.94 |
| Debt / FCF | 2.05 |
| Interest Coverage | 18.31 |
Financial Efficiency
Return on equity (ROE) is 10.70% and return on invested capital (ROIC) is 9.06%.
| Return on Equity (ROE) | 10.70% |
| Return on Assets (ROA) | 7.23% |
| Return on Invested Capital (ROIC) | 9.06% |
| Return on Capital Employed (ROCE) | 14.84% |
| Revenue Per Employee | 1.03B |
| Profits Per Employee | 81.41M |
| Employee Count | 178 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 3.41 |
Taxes
In the past 12 months, Englewood Lab has paid 5.77 billion in taxes.
| Income Tax | 5.77B |
| Effective Tax Rate | 28.47% |
Stock Price Statistics
The stock price has increased by +4.70% in the last 52 weeks. The beta is 0.63, so Englewood Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +4.70% |
| 50-Day Moving Average | 13,039.80 |
| 200-Day Moving Average | 9,743.60 |
| Relative Strength Index (RSI) | 43.54 |
| Average Volume (20 Days) | 273,543 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Englewood Lab had revenue of KRW 183.82 billion and earned 14.49 billion in profits. Earnings per share was 735.08.
| Revenue | 183.82B |
| Gross Profit | 42.92B |
| Operating Income | 22.55B |
| Pretax Income | 20.26B |
| Net Income | 14.49B |
| EBITDA | 27.76B |
| EBIT | 22.55B |
| Earnings Per Share (EPS) | 735.08 |
Balance Sheet
The company has 34.79 billion in cash and 26.05 billion in debt, giving a net cash position of 8.73 billion or 433.47 per share.
| Cash & Cash Equivalents | 34.79B |
| Total Debt | 26.05B |
| Net Cash | 8.73B |
| Net Cash Per Share | 433.47 |
| Equity (Book Value) | 140.48B |
| Book Value Per Share | 6,767.96 |
| Working Capital | 102.72B |
Cash Flow
In the last 12 months, operating cash flow was 16.56 billion and capital expenditures -3.88 billion, giving a free cash flow of 12.68 billion.
| Operating Cash Flow | 16.56B |
| Capital Expenditures | -3.88B |
| Free Cash Flow | 12.68B |
| FCF Per Share | 629.45 |
Margins
Gross margin is 23.35%, with operating and profit margins of 12.27% and 7.88%.
| Gross Margin | 23.35% |
| Operating Margin | 12.27% |
| Pretax Margin | 11.02% |
| Profit Margin | 7.88% |
| EBITDA Margin | 15.10% |
| EBIT Margin | 12.27% |
| FCF Margin | 6.90% |
Dividends & Yields
This stock pays an annual dividend of 103.00, which amounts to a dividend yield of 0.77%.
| Dividend Per Share | 103.00 |
| Dividend Yield | 0.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 13.85% |
| Buyback Yield | 0.91% |
| Shareholder Yield | 1.68% |
| Earnings Yield | 5.55% |
| FCF Yield | 4.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Englewood Lab has an Altman Z-Score of 4.08 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.08 |
| Piotroski F-Score | 6 |